{"id":54733,"date":"2020-04-15T10:45:23","date_gmt":"2020-04-15T13:45:23","guid":{"rendered":"http:\/\/www.lorena.sp.gov.br\/wordpress\/?p=54733"},"modified":"2020-04-15T10:45:23","modified_gmt":"2020-04-15T13:45:23","slug":"calendario-vacinal-de-2020-passa-por-modificacoes-em-relacao-ao-ano-anterior-entenda-as-mudancas","status":"publish","type":"post","link":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/2020\/04\/15\/calendario-vacinal-de-2020-passa-por-modificacoes-em-relacao-ao-ano-anterior-entenda-as-mudancas\/","title":{"rendered":"Calend\u00e1rio Vacinal de 2020 passa por modifica\u00e7\u00f5es em rela\u00e7\u00e3o ao ano anterior. Entenda as mudan\u00e7as"},"content":{"rendered":"

A Secretaria de Estado de Sa\u00fade divulgou uma atualiza\u00e7\u00e3o do Calend\u00e1rio Nacional de Vacina\u00e7\u00e3o 2020. O texto traz altera\u00e7\u00f5es em rela\u00e7\u00e3o \u00e0s recomenda\u00e7\u00f5es para as imuniza\u00e7\u00f5es. As mudan\u00e7as j\u00e1 haviam sido anunciadas em dezembro do ano passado pelo Minist\u00e9rio da Sa\u00fade. Entenda as modifica\u00e7\u00f5es:<\/span><\/p>\n\n\n\n\n\n\n\n\n
Vacina<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nRecomenda\u00e7\u00f5es<\/span> em<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

2019\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n

Passa<\/span> a <\/span>vigorar<\/span> em<\/span> 2020\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nJustificativa<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
Meningoc\u00f3cica<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

C (<\/span>Conjugada<\/span>)\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Recomendada<\/span> para <\/span>crian\u00e7as<\/span> < 5 <\/span>anos<\/span> de <\/span>acordo<\/span> com a <\/span>situa\u00e7\u00e3o<\/span> vacinal<\/span> e <\/span>adolescentes<\/span> de 11 a 14 <\/span>anos<\/span> de\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

idade<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Recomendada<\/span> <\/span>para <\/span>crian\u00e7as<\/span> < 5 <\/span>anos<\/span> de <\/span>idade<\/span>, de <\/span>acordo<\/span> com a <\/span>situa\u00e7\u00e3o<\/span> vacinal<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nGarantir<\/span> a <\/span>sustentabilidade<\/span> da <\/span>oferta<\/span> da <\/span>vacina<\/span> contendo<\/span> o <\/span>sorotipo<\/span> C<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
Meningoc\u00f3cica<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

ACWY\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

(<\/span>Conjugada<\/span>)\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Recomendada<\/span> para <\/span>adolescentes<\/span> de <\/span><\/span>11 a 12 <\/span>anos<\/span><\/span><\/b> de <\/span>idade<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nRecomendada<\/span> <\/span>para <\/span>adolescentes<\/span> de\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

11 a 12 <\/span>anos<\/span><\/span><\/b> de <\/span>idade<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n

Garantir<\/span> a <\/span>sustentabilidade<\/span> da <\/span>oferta<\/span> da <\/span>vacina<\/span> contendo<\/span> o <\/span>sorotipo<\/span> C para as <\/span>crian\u00e7as<\/span> < 5 <\/span>anos<\/span>, <\/span>al\u00e9m<\/span> de <\/span>proteger<\/span> contra o <\/span>sorogrupo<\/span> W, <\/span>considerando<\/span> a <\/span>gravidade<\/span> da <\/span>doen\u00e7a<\/span>.<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Febre <\/span>amarela<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Residentes<\/span> das <\/span>\u00e1reas<\/span> com <\/span>recomenda\u00e7\u00e3o<\/span> para <\/span>vacina\u00e7\u00e3o<\/span> (ACRV) e <\/span>viajantes<\/span> que se <\/span>deslocavam<\/span> para <\/span>essas<\/span> \u00e1reas<\/span> ou<\/span> pa\u00edses<\/span> end\u00eamicos<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nTodos<\/span> os<\/span> munic\u00edpios<\/span> do <\/span>Brasil<\/span> passam<\/span> a ser <\/span>\u00e1rea<\/span> com <\/span>recomenda\u00e7\u00e3o<\/span> de <\/span>vacina\u00e7\u00e3o<\/span> (ACRV). <\/span>Viajantes<\/span> para <\/span>pa\u00edses<\/span> que <\/span>exigem<\/span> o <\/span>Certif<\/span><\/span>icado<\/span> Internacional<\/span> de\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Vacina\u00e7\u00e3o<\/span> e <\/span>Profilaxia<\/span> (CIVP).\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Proteger<\/span> toda<\/span> a <\/span>popula\u00e7\u00e3o<\/span> contra a <\/span>febre<\/span> amarela<\/span> que causa <\/span>surtos<\/span> espor\u00e1dicos<\/span> com <\/span>impacto<\/span> para a <\/span>sa\u00fade<\/span> p\u00fablica<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Dose <\/span>\u00fanica<\/span> v\u00e1lida<\/span> para <\/span>toda<\/span> vida<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Crian\u00e7as<\/span>< 5 <\/span>anos<\/span>:<\/span><\/span><\/b> 1\u00aa <\/span><\/span>dose <\/span>aos<\/span> 9 <\/span>meses<\/span> de <\/span>vida<\/span> e a 2\u00aa dose (<\/span>refor\u00e7o<\/span>) <\/span>aos<\/span> 4 <\/span>anos<\/span> de <\/span>idade<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Pessoas a <\/span>partir<\/span> de 5 <\/span>anos<\/span> de <\/span>idade<\/span> n\u00e3o<\/span> vacinadas<\/span>, <\/span>ou<\/span> sem<\/span> comprovante<\/span> de <\/span>vacina\u00e7\u00e3o<\/span>: <\/span><\/span><\/b>aplicar<\/span> uma<\/span> dose que <\/span>ser\u00e1<\/span> v\u00e1lida<\/span> para <\/span>toda<\/span> vida<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Caso a <\/span>pessoa<\/span> tenha<\/span> recebido<\/span> apenas<\/span> uma<\/span> dose da <\/span>v<\/span><\/span>acina<\/span> febre<\/span> amarela<\/span> antes de <\/span>completar<\/span> 5 <\/span>anos<\/span> de <\/span>idade<\/span>, <\/span>dever\u00e1<\/span> receber<\/span> uma<\/span> dose <\/span>adicional<\/span>, <\/span>independentemente<\/span> da <\/span>idade<\/span> em<\/span> que <\/span>o<\/span> indiv\u00edduo<\/span> procure o <\/span>servi\u00e7o<\/span> de <\/span>vacina\u00e7\u00e3o<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n

Poliomielite<\/span> oral\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nRepetir<\/span> a dose <\/span>se<\/span> a <\/span>crian\u00e7a<\/span> regurgitar<\/span>, <\/span>cuspir<\/span> ou<\/span> vomitar<\/span>.<\/span><\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nN\u00e3o<\/span> repetir<\/span> a dose <\/span>se<\/span> a <\/span>crian\u00e7a<\/span> regurgitar<\/span>, <\/span>vomitar<\/span> ou<\/span> cuspir<\/span>\u00a0\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nA VOP \u00e9 <\/span>aplicada<\/span> em<\/span> crian\u00e7as<\/span> maiores<\/span> (<\/span>refor\u00e7os<\/span> com 1 e 4 <\/span>anos<\/span>), <\/span>portanto<\/span>: <\/span>raro<\/span> regurgitar<\/span>; a VOP <\/span>tem<\/span> uma<\/span> excelente<\/span> absor\u00e7\u00e3o<\/span> na<\/span> mucosa oral e \u00e9 <\/span>dif\u00edcil<\/span> mensurar<\/span> se a <\/span>crian\u00e7a<\/span> vomitou<\/span> as 2 <\/span>gotas<\/span> <\/span>aplicadas<\/span>.\u00a0<\/span><\/span>
\n<\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n
<\/td>\n<\/tr>\n
Vacina<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nRecomenda\u00e7\u00f5es<\/span> em<\/span> 2019\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nPassa<\/span> a <\/span>vigorar<\/span> em<\/span> 2020\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nJustificativa<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
Influenza\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n\u00a0<\/span><\/td>\nCrian\u00e7as<\/span> de 6 <\/span>meses<\/span> a <6 <\/span>anos<\/span>; <\/span>indiv\u00edduos<\/span> com 60 <\/span>anos<\/span> ou<\/span> mais<\/span> de <\/span>idade<\/span> e <\/span>grupos<\/span> espec\u00edficos<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nCrian\u00e7as<\/span> de 6 <\/span>meses<\/span> a < 6\u00a0 <\/span><\/span>anos<\/span>; <\/span>indiv\u00edduos<\/span> com 55 <\/span>anos<\/span> ou<\/span> mais<\/span> de <\/span>idade<\/span> e <\/span>grupos<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

espec\u00edficos<\/span>\u00a0\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Reduzir<\/span> as <\/span>complica\u00e7\u00f5es<\/span>, as <\/span>interna\u00e7\u00f5es<\/span> e a <\/span>mortalidade<\/span> decorrentes<\/span> das <\/span>infec\u00e7\u00f5es<\/span> pelo<\/span> v\u00edrus<\/span> influenza, <\/span>na<\/span> popula\u00e7\u00e3o<\/span> alvo<\/span> para a <\/span>vacina\u00e7\u00e3o<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n

dTpa<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n\u00a0<\/span><\/td>\nRecomendada<\/span> para <\/span>os<\/span> seguintes<\/span> profissionais<\/span> de <\/span>sa\u00fade<\/span>:\u00a0\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

M\u00e9dico<\/span> <\/span>anestesista<\/span>, <\/span>ginecologista<\/span>, <\/span><\/span>obstetra<\/span>, <\/span>neonatologista<\/span>, <\/span><\/span>pediatra<\/span>, <\/span>enfermeiro<\/span>, <\/span><\/span>t\u00e9cnico<\/span> <\/span>de <\/span>enfermagem<\/span> <\/span>e <\/span><\/span>demais<\/span> profissionais<\/span> <\/span>que <\/span><\/span>atendam<\/span> rec\u00e9m-nascidos<\/span> <\/span>nas<\/span> maternidades<\/span> e <\/span>ber\u00e7\u00e1rios<\/span>\/UTI <\/span>ne<\/span><\/span>onatais<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Recomendada<\/span> para <\/span>todos<\/span> os<\/span> profissionais<\/span> de <\/span>sa\u00fade<\/span>, <\/span>incluindo<\/span> as <\/span>parteiras<\/span> tradicionais<\/span>, <\/span>considerando<\/span> o <\/span>hist\u00f3rico<\/span> vacinal<\/span> de <\/span>difteria<\/span>, <\/span>t\u00e9tano<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Os<\/span> profissionais<\/span> com <\/span>esquema<\/span> de <\/span>vacina\u00e7\u00e3o<\/span> prim\u00e1rio<\/span> completo<\/span>, <\/span>administrar<\/span> a <\/span>vacina<\/span> dTpa<\/span> como<\/span> <\/span>refor\u00e7o<\/span> a <\/span>ca<\/span><\/span><\/b>da<\/span> 10<\/span><\/span><\/b> anos<\/span> em<\/span> substitui\u00e7\u00e3o<\/span> da <\/span>dT.<\/span><\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Diminuir<\/span> o <\/span>risco<\/span> da <\/span>transmiss\u00e3o<\/span> <\/span>da <\/span>coqueluche<\/span> em<\/span> RN e <\/span>crian\u00e7as<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
Varicela<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n\u00a0<\/span><\/td>\nProfissionais<\/span> de <\/span>sa\u00fade<\/span> suscet\u00edveis<\/span> \u00e0 <\/span>doen\u00e7a<\/span> que <\/span>estejam<\/span> em<\/span> conv\u00edvio<\/span> hospitalar<\/span> com <\/span><\/span>pacientes<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

imunodeprimidos<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

\n
    \n
  1. Profissionais<\/span> de <\/span>sa\u00fade<\/span> n\u00e3o<\/span> vacinados<\/span> e que <\/span>trabalham<\/span> na<\/span> \u00e1rea<\/span> assistencial<\/span>, <\/span>especialmente<\/span> em<\/span> contato<\/span> com <\/span>pessoas<\/span> imunodeprimidas<\/span> e <\/span>os<\/span> da <\/span>\u00e1rea<\/span> de <\/span>pediatria<\/span> devem<\/span> receber<\/span> uma<\/span> ou<\/span> duas<\/span> doses de <\/span>vacina<\/span> varicela<\/span> (<\/span>atenuada<\/span>), a <\/span>depender<\/span> do <\/span>laborat\u00f3rio<\/span> produtor<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n<\/ol>\n
      \n
    1. Va<\/span><\/span>cina\u00e7\u00e3o<\/span> de <\/span>contatos<\/span> de <\/span>casos<\/span> suspeitos<\/span> ou<\/span> confirmados<\/span> em<\/span> situa\u00e7\u00e3o<\/span> de <\/span>surto<\/span> de <\/span>varicela<\/span> em<\/span> <\/span>creche.<\/span><\/span><\/b>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n<\/ol>\n<\/td>\n
Diminuir<\/span> o <\/span>risco<\/span> da <\/span>transmiss\u00e3o<\/span> <\/span>da <\/span>varicela<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
SCR \u2013 <\/span>Bloqueio<\/span> vacinal<\/span> dos <\/span>contatos<\/span> de <\/span>casos<\/span> suspeitos<\/span> ou<\/span> confirmados<\/span> de\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

sarampo<\/span> e <\/span>rub\u00e9ola<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Vacina\u00e7\u00e3o<\/span> de <\/span>crian\u00e7as<\/span> de 6 a 11 <\/span>meses<\/span> (dose zero) e de <\/span>pessoas<\/span> de 12 <\/span>meses<\/span> a 49 <\/span>anos<\/span> aplicar<\/span> a dose de <\/span>acordo<\/span> com o <\/span>calend\u00e1rio<\/span> <\/span>nacional<\/span> <\/span>de <\/span>vacina\u00e7\u00e3o<\/span>.\u00a0\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nVacina\u00e7\u00e3o<\/span> de <\/span>crian\u00e7as<\/span> de 6 a 11 <\/span>meses<\/span> (dose zero) e de <\/span>pessoas<\/span> de 12 <\/span>meses<\/span> a 49 <\/span>anos<\/span> aplicar<\/span> a dose de<\/span><\/span> acordo<\/span> com o <\/span>calend\u00e1rio<\/span> nacional<\/span> de <\/span>vacina\u00e7\u00e3o<\/span>.\u00a0\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Indicado<\/span> uma<\/span> dose de <\/span>vacina<\/span> contendo<\/span> os<\/span> componentes<\/span> sarampo<\/span> e <\/span>rub\u00e9ola<\/span> em<\/span> pessoas<\/span> a <\/span>partir<\/span> de 60 <\/span>anos<\/span> de <\/span>idade<\/span> n\u00e3o<\/span> vacinadas<\/span> ou<\/span> sem<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

comprovante<\/span> de <\/span>vacina\u00e7\u00e3o<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n

Controlar<\/span> casos<\/span> de <\/span>sarampo<\/span> ou<\/span> rub\u00e9ola<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
HPV\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nO <\/span>esquema<\/span> recomendado<\/span> para a <\/span>faixa<\/span> et\u00e1ria<\/span> contemplada<\/span> \u00e9 de <\/span>duas<\/span> doses, com <\/span>intervalo<\/span> de 6 <\/span>meses<\/span>. <\/span>Recomenda<\/span>-se que <\/span>o<\/span> intervalo<\/span> entre as doses <\/span>n\u00e3o<\/span> seja<\/span> superior a 12-15 <\/span>meses<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nPara <\/span>os<\/span> adolescentes<\/span> que <\/span>receberam<\/span> a 1\u00aa dose <\/span>aos<\/span> 14 <\/span>anos<\/span> de <\/span>idade<\/span>, a 2\u00aa dose <\/span>deve<\/span><\/span>r\u00e1<\/span> ser <\/span>administrada<\/span> com <\/span>intervalo<\/span> m\u00ednimo<\/span> de 6 <\/span>meses<\/span> e <\/span>m\u00e1ximo<\/span> de <\/span>at\u00e9<\/span> 12 <\/span>meses<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Para que <\/span>o<\/span> esquema<\/span> seja<\/span> completado<\/span> o <\/span>mais<\/span> breve <\/span>poss\u00edvel<\/span>, <\/span>visando<\/span> garantir<\/span> uma<\/span> elevada<\/span> produ\u00e7\u00e3o<\/span> de <\/span>anticorpos<\/span> e <\/span>a<\/span> efetividade<\/span> da <\/span>vacina\u00e7\u00e3o<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\n

A Secretaria de Estado de Sa\u00fade tamb\u00e9m divulgou mudan\u00e7as no Programa Estadual de Imuniza\u00e7\u00f5es:<\/span><\/p>\n\n\n\n\n\n\n\n\n\n
Vacina<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nRecomenda\u00e7\u00e3o<\/span> do PEI\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nRecomenda\u00e7\u00e3o<\/span> do PNI\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n<\/tr>\n

BCG\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n\u00c9 <\/span>indicada<\/span>, <\/span>prioritariamente<\/span>, para <\/span>pessoas<\/span> com <\/span>at\u00e9<\/span> 15 <\/span>anos<\/span> de <\/span>idade<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nA <\/span>vacina<\/span> est\u00e1<\/span> disponibilizada<\/span> para <\/span>crian\u00e7as<\/span> < 5 <\/span>anos<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
Hepatite<\/span> B\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nRN de <\/span>m\u00e3e<\/span> AgsHB<\/span>+, \u00e9 fundamental <\/span>a<\/span> administra\u00e7\u00e3o<\/span> precoce<\/span> da <\/span>vacina<\/span> contra <\/span>hepatite<\/span> B, <\/span>preferentemente<\/span> nas<\/span> primeiras<\/span> 12 horas, <\/span>bem<\/span> como<\/span> da <\/span>imunoglobulina<\/span> humana<\/span> espec\u00edfica<\/span> (IGHB – 0,5 mL), <\/span>em<\/span><\/span> s\u00edtios<\/span> musculares<\/span> distintos<\/span>. A <\/span>vacina<\/span> deve<\/span> ser <\/span>utilizada<\/span> mesmo<\/span> que <\/span>a<\/span> imunoglobulina<\/span> n\u00e3o<\/span> seja<\/span> dispon\u00edvel<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

RN de <\/span>m\u00e3es<\/span> AgHBs<\/span>+, <\/span>profissionais<\/span> da <\/span>sa\u00fade<\/span> em<\/span> risco<\/span> de <\/span>acidente<\/span> com material <\/span>biol\u00f3gico<\/span>, <\/span>pacientes<\/span> submetidos<\/span> \u00e0 <\/span>hemodi\u00e1lise<\/span>, <\/span>pessoas<\/span> infectadas<\/span> pelo<\/span> HIV e outros <\/span>imunocomprometidos<\/span>, <\/span>parceiros<\/span> sexuais<\/span> e <\/span>aqueles<\/span> que <\/span>compartilham<\/span> agulhas<\/span> com <\/span>pessoas<\/span> AgsHB<\/span>+ <\/span>pode<\/span><\/span>m<\/span> necessitar<\/span> de <\/span>avalia\u00e7\u00e3o<\/span> da <\/span>concentra\u00e7\u00e3o<\/span> protetora<\/span> de anti-HBs. <\/span>Recomenda<\/span>-se <\/span>nestas<\/span> situa\u00e7\u00f5es<\/span> teste <\/span>sorol\u00f3gico<\/span> quantitativo<\/span> um a <\/span>dois<\/span> meses<\/span> ap\u00f3s<\/span> a <\/span>\u00faltima<\/span> dose da <\/span>vacina<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

RN de <\/span>m\u00e3es<\/span> HBsAg <\/span>reagente<\/span> devem<\/span> receber<\/span> a<\/span> imunoglobulina<\/span> anti-<\/span>hepatite<\/span> B, e a <\/span>prim<\/span><\/span>eira<\/span> dose da <\/span>vacina<\/span> hepatite<\/span> B (HBV) <\/span>nas<\/span> primeiras<\/span> 12\/24 horas. <\/span>A<\/span> avalia\u00e7\u00e3o<\/span> da <\/span>soroconvers\u00e3o<\/span> deve<\/span> ser <\/span>realizada<\/span> mediante<\/span> anti-HBs entre 30 a 60 <\/span>dias<\/span> ap\u00f3s<\/span> a <\/span>\u00faltima<\/span> dose da <\/span>vacina<\/span> que <\/span>cont\u00e9m<\/span> o <\/span>componente<\/span> para <\/span>hepatite<\/span> B.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
Pentavalente<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

(DTP-Hib-Hep\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

B)\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

N\u00c3O<\/span><\/span> deve<\/span> ser <\/span>administrada<\/span> antes de 6 <\/span>semanas<\/span> de <\/span>vida<\/span>, pois <\/span>poder\u00e1<\/span> induzir<\/span> toler\u00e2ncia<\/span> imunol\u00f3gica<\/span> \u00e0s<\/span> doses <\/span>adicionais<\/span> dos <\/span>componentes<\/span> Hib e\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Pertussis.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

_____________\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n

VIP\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nRecomendada<\/span> para <\/span>crian\u00e7as<\/span> e <\/span>adolescentes<\/span> (<\/span>at\u00e9<\/span> 19 <\/span>anos<\/span>) <\/span>n\u00e3o<\/span> vacinados<\/span> ou<\/span> incompletamente<\/span> vacinados<\/span> ou<\/span> sem<\/span> comprova\u00e7\u00e3o<\/span> de dose <\/span>recebida<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

A <\/span>vacina<\/span> est\u00e1<\/span> disponibilizada<\/span> para <\/span>crian\u00e7as<\/span> < 5 <\/span>anos<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
VOP\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nAdministrar<\/span> o 1\u00ba <\/span>refor\u00e7o<\/span> aos<\/span> 15 <\/span>meses<\/span> e o <\/span>segundo<\/span> refor\u00e7o<\/span> entre 4 e 6 <\/span>anos<\/span> de <\/span>idade<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Pessoas \u2265 20 <\/span>anos<\/span> de <\/span>idade<\/span>, <\/span>sem<\/span> comprova\u00e7\u00e3o<\/span> vacinal<\/span> ou<\/span> com <\/span>esquema<\/span> incompleto<\/span>, <\/span>dever\u00e3o<\/span> receber<\/span> a <\/span><\/span>VIP<\/span><\/span><\/b>, se <\/span>forem<\/span> viajantes<\/span> se <\/span>deslocando<\/span> para <\/span>\u00e1reas<\/span> com <\/span>recomenda\u00e7\u00e3o<\/span> da <\/span>vaci<\/span><\/span>na<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

Administrar<\/span> o 1\u00ba <\/span>refor\u00e7o<\/span> aos<\/span> 15 <\/span>meses<\/span> e o <\/span>segundo<\/span> aos<\/span> 4 <\/span>anos<\/span> de <\/span>idade<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

Pessoas \u2265 5 <\/span>anos<\/span> de <\/span>idade<\/span>, <\/span>sem<\/span> comprova\u00e7\u00e3o<\/span> vacinal<\/span> ou<\/span> com <\/span>esquema<\/span> incompleto<\/span>, <\/span>dever\u00e3o<\/span> receber<\/span> a <\/span><\/span>VOP<\/span><\/span><\/b>, <\/span>excepcionalmente<\/span>, se <\/span>forem<\/span> viajantes<\/span> se <\/span>deslocando<\/span> para <\/span>\u00e1reas<\/span> com <\/span>recomenda\u00e7<\/span><\/span>\u00e3o<\/span> da <\/span>vacina<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n

Pneumoc\u00f3cica<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

10 <\/span>valente<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

N\u00c3O <\/span>deve<\/span> ser <\/span>administrada<\/span> antes de 6 <\/span>semanas<\/span> de <\/span>vida<\/span>, pois <\/span>poder\u00e1<\/span> induzir<\/span> toler\u00e2ncia<\/span> imunol\u00f3gica<\/span> \u00e0s<\/span> doses <\/span>adicionais<\/span>.<\/span><\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

_____________\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n
<\/td>\n<\/tr>\n
Vacina<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nRecomenda\u00e7\u00e3o<\/span> do PEI\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nRecomenda\u00e7\u00e3o<\/span> do PNI<\/span><\/span><\/b>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n<\/tr>\n

Febre <\/span>amarela<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n1) <\/span>Vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> em<\/span> crian\u00e7as<\/span> < 2 <\/span>anos<\/span>\u00a0\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n
    \n
  • Para a <\/span>crian\u00e7a<\/span> <\/span>que <\/span>recebeu<\/span> anteriormente<\/span><\/span><\/b> as <\/span>vacinas<\/span> tr\u00edplice<\/span> viral e <\/span>febre<\/span> amarela<\/span>, <\/span>n\u00e3o<\/span> h\u00e1<\/span> evid\u00eancias<\/span> de <\/span>interfer\u00eancia<\/span> na<\/span> imunogenicidade<\/span> <\/span>entre <\/span>elas<\/span>, as <\/span>duas<\/span> poder\u00e3o<\/span> ser <\/span>administradas<\/span> simultaneamente<\/span> ou<\/span> com <\/span>intervalo<\/span> de <\/span><\/span>4 <\/span>semanas<\/span>.\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/li>\n<\/ul>\n

    \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

    \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

    \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

    \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

      \n
    • Nesse <\/span>momento<\/span>, <\/span>frente<\/span> a<\/span> atual<\/span> situa\u00e7\u00e3o<\/span> epidemiol\u00f3gica<\/span> de <\/span>surto<\/span> ativo<\/span> de <\/span>sarampo<\/span> em<\/span> v\u00e1rios<\/span> munic\u00edpios<\/span> do <\/span>estado<\/span> de S\u00e3o Paulo, <\/span>refor\u00e7a<\/span>–<\/span>se a<\/span> necessidade<\/span> de <\/span>p<\/span><\/span>riorizar<\/span> a <\/span>vacina\u00e7\u00e3o<\/span> com as <\/span>vacinas<\/span> tr\u00edplice<\/span> viral (SCR) e <\/span>tetraviral<\/span>, <\/span>devendo<\/span>-se <\/span>agendar<\/span> a dose da <\/span>vacina<\/span> febre<\/span> amarela<\/span> com <\/span>intervalo<\/span> de <\/span><\/span>4 <\/span>semanas<\/span>.\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/li>\n<\/ul>\n

      \u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

      2) <\/span>Vacina\u00e7\u00e3o<\/span> de <\/span>pessoas<\/span> \u2265 60 <\/span>anos<\/span> nunca<\/span> vacinados<\/span>– <\/span><\/span><\/b>Como o <\/span>estado<\/span> de S\u00e3o Paulo \u00e9 ACRV <\/span>recomenda<\/span>–<\/span><\/span>se a<\/span> vacina\u00e7\u00e3o<\/span> desta<\/span> popula\u00e7\u00e3o<\/span>, no <\/span>entanto<\/span>, o <\/span>servi\u00e7o<\/span> de <\/span>sa\u00fade<\/span> dever\u00e1<\/span> avaliar<\/span> doen\u00e7as<\/span> pr\u00e9vias<\/span> (<\/span>comorbidades<\/span>), <\/span>doen\u00e7as<\/span> autoimunes<\/span>, <\/span>tratamentos<\/span> espec\u00edficos<\/span> ou<\/span> uso<\/span> cont\u00ednuo<\/span> de <\/span>medicamentos<\/span> que <\/span>contraindiquem<\/span> a<\/span> aplica\u00e7\u00e3o<\/span> da <\/span>vacina<\/span> febre<\/span> amarela<\/span> nesta<\/span> faixa<\/span> et\u00e1<\/span><\/span>ria<\/span>.\u00a0\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

      \u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

1) <\/span>Vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> em<\/span> crian\u00e7as<\/span> < 2 <\/span>anos<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n
    \n
  • Para a <\/span>crian\u00e7a<\/span> que <\/span>recebeu<\/span> anteriormente<\/span> as <\/span>vacinas<\/span> tr\u00edplice<\/span> viral e <\/span>febre<\/span> amarela<\/span>, <\/span>n\u00e3o<\/span> h\u00e1<\/span> evid\u00eancias<\/span> de <\/span>interfer\u00eancia<\/span> na<\/span> imunogenicidade<\/span> entre <\/span>elas<\/span>, as <\/span>duas<\/span> poder\u00e3o<\/span> ser <\/span>administradas<\/span> simultaneamente<\/span> o<\/span><\/span>u<\/span> sem<\/span> intervalo<\/span> m\u00ednimo<\/span> entre as doses. Se a <\/span>crian\u00e7a<\/span> recebeu<\/span> apenas<\/span> uma<\/span> das <\/span>vacinas<\/span> (<\/span>tr\u00edplice<\/span> viral <\/span>ou<\/span> febre<\/span> amarela<\/span>), <\/span>estabelecer<\/span> preferivelmente<\/span> o <\/span>intervalo<\/span> de 30 <\/span>dias<\/span> entre as doses (<\/span><\/span>m\u00ednimo<\/span> 15 <\/span>dias<\/span><\/span><\/b>).\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n
  • Em<\/span> situa\u00e7\u00f5es<\/span> onde<\/span> exista<\/span> o <\/span>risco<\/span> epidemiol\u00f3gico<\/span> conco<\/span><\/span>mitante<\/span> para <\/span>febre<\/span> amarela<\/span> e <\/span>os<\/span> v\u00edrus<\/span> contidos<\/span> na<\/span> vacina<\/span> tr\u00edplice<\/span> viral, o <\/span>risco<\/span> da <\/span>n\u00e3o<\/span> vacina\u00e7\u00e3o<\/span> \u00e9 <\/span>maior<\/span> que a <\/span>possibilidade<\/span> da <\/span>diminui\u00e7\u00e3o<\/span> da <\/span>resposta<\/span> imune<\/span>. Dessa forma a <\/span>vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> dever\u00e1<\/span> ser <\/span>realizada<\/span> sem<\/span> levar<\/span> em<\/span> conta<\/span> o <\/span>intervalo<\/span> entre as d<\/span><\/span>oses.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n<\/ul>\n

    \u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

    2) <\/span>Vacina\u00e7\u00e3o<\/span> de <\/span>pessoas<\/span> \u2265 60 <\/span>anos<\/span> nunca<\/span> vacinados<\/span>– <\/span><\/span><\/b>O <\/span>servi\u00e7o<\/span> de <\/span>sa\u00fade<\/span> dever\u00e1<\/span> avaliar<\/span> a <\/span>pertin\u00eancia<\/span> da <\/span>vacina\u00e7\u00e3o<\/span>, <\/span>levando<\/span> em<\/span> conta<\/span> o <\/span>risco<\/span> da <\/span>doen\u00e7a<\/span> e o <\/span>risco<\/span> de <\/span>eventos<\/span> adversos<\/span> nessa<\/span> faixa<\/span> et\u00e1ria<\/span> e\/<\/span>ou<\/span> decorrentes<\/span> de <\/span>comorbidades<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n

SCR\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n\n
    \n
  1. Recomendada<\/span> para <\/span>pessoas<\/span> de 12 <\/span>meses<\/span> at\u00e9<\/span> os<\/span> nascidos<\/span> a <\/span>partir<\/span> de 1960.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n<\/ol>\n
      \n
    1. Pessoas de 5 a 29 <\/span>anos<\/span> de <\/span>idade<\/span> n\u00e3o<\/span> vacinadas<\/span> ou<\/span> com <\/span>esquema<\/span> incompleto<\/span><\/span><\/b>– <\/span>Considerar<\/span> vacinada<\/span> a <\/span>pessoa<\/span> que <\/span>comprovar<\/span> 2 doses de SCR e\/<\/span>ou<\/span> tetra viral.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n<\/ol>\n

      \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

        \n
      1. Pessoas de 30 <\/span>at\u00e9<\/span> os<\/span> nascidos<\/span> a <\/span>partir<\/span> de 1960 –\u00a0<\/span><\/span><\/b> Considerar<\/span> vacinada<\/span> contra o <\/span>sarampo<\/span> a <\/span>pessoa<\/span> que <\/span>comprovar<\/span> 1 dose da <\/span>vacina<\/span> tr\u00edplice<\/span> viral.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n<\/ol>\n

        \u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

          \n
        1. Vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> em<\/span> crian\u00e7as<\/span> < 2 <\/span>anos<\/span>– <\/span><\/span><\/b>Para a <\/span>crian\u00e7a<\/span> que <\/span>recebeu<\/span> anteriormente<\/span> as <\/span>vacinas<\/span> SCR e <\/span>febre<\/span> ama<\/span><\/span>rela<\/span>, as <\/span>duas<\/span> poder\u00e3o<\/span> ser <\/span>administradas<\/span> simultaneamente<\/span> ou<\/span> com <\/span>intervalo<\/span> m\u00ednimo<\/span> de <\/span><\/span>4 <\/span>semanas<\/span>.\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/li>\n<\/ol>\n

          \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

          \u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n

\n
    \n
  1. Recomendada<\/span> para <\/span>pessoas<\/span> de 12 <\/span>meses<\/span> a 59 <\/span>anos<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n<\/ol>\n
      \n
    1. Pessoas de 5 a 29 <\/span>anos<\/span> de <\/span>idade<\/span> n\u00e3o<\/span> vacinadas<\/span> ou<\/span> com <\/span>esquema<\/span> incompleto<\/span><\/span><\/b>– <\/span><\/span>Considerar<\/span> vacinada<\/span> a <\/span>pessoa<\/span> que <\/span>comprovar<\/span> 2 doses de <\/span>vacina<\/span> contendo<\/span> os<\/span> componentes<\/span> sarampo<\/span> e <\/span>rub\u00e9ola<\/span> (<\/span>dupla<\/span> viral, SCR <\/span>ou<\/span> tetra viral).<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/li>\n<\/ol>\n
        \n
      1. Pessoas de 30 a 59 <\/span>anos<\/span> de <\/span>idade<\/span>–\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/li>\n<\/ol>\n

        Considerar<\/span> vacinada<\/span> contra o <\/span>sarampo<\/span> a <\/span>pessoa<\/span> que <\/span>comprovar<\/span> 1 dose de <\/span>vacina<\/span> conte<\/span><\/span>ndo<\/span> o <\/span>componente<\/span> sarampo<\/span> (<\/span>monovalente<\/span>, <\/span>dupla<\/span> viral <\/span>ou<\/span> SCR).\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

          \n
        1. Vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> em<\/span> crian\u00e7as<\/span> < 2 <\/span>anos<\/span><\/span><\/b>– Para a <\/span>crian\u00e7a<\/span> que <\/span>recebeu<\/span> anteriormente<\/span> as <\/span>vacinas<\/span> SCR e <\/span>febre<\/span> amarela<\/span>, as <\/span>duas<\/span> poder\u00e3o<\/span> ser <\/span>administradas<\/span> simultaneamente<\/span> ou<\/span> sem<\/span> intervalo<\/span> m\u00ednimo<\/span> entre<\/span><\/span> as doses. Se a <\/span>crian\u00e7a<\/span> recebeu<\/span> apenas<\/span> uma<\/span> das <\/span>vacinas<\/span> (SCR <\/span>ou<\/span> febre<\/span> amarela<\/span>), <\/span>estabelecer<\/span> preferivelmente<\/span> o <\/span>intervalo<\/span> de 30 <\/span>dias<\/span> entre as doses (<\/span><\/span>m\u00ednimo<\/span> 15 <\/span>dias<\/span><\/span><\/b>).\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n<\/ol>\n

          \u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n
          <\/td>\n<\/tr>\n
          Vacina<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\nRecomenda\u00e7\u00e3o<\/span> do PEI (Programa Estadual de Imuniza\u00e7\u00e3o)\u00a0 <\/span><\/span><\/b>
          \n<\/span><\/span><\/td>\n          		Recomenda\u00e7\u00e3o<\/span> do PNI (Programa Nacional de Imuniza\u00e7\u00e3o)<\/span><\/span><\/b>
          \n<\/span><\/span><\/p>\n

          \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n<\/tr>\n

          SCR\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n5<\/span><\/span><\/b>) <\/span>Vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> em<\/span> crian\u00e7as<\/span> < 2 <\/span>anos<\/span><\/span><\/b>– Nesse <\/span>momento<\/span>, <\/span>frente<\/span> a<\/span> atual<\/span> situa\u00e7\u00e3o<\/span> epidemiol\u00f3gica<\/span> de <\/span>surto<\/span> ativo<\/span> de <\/span>sarampo<\/span> em<\/span> v\u00e1rios<\/span> munic\u00edpios<\/span> do <\/span>estado<\/span> de S\u00e3o Paulo, <\/span>refor\u00e7a<\/span>–<\/span>se a<\/span> necessidade<\/span> de <\/span>priorizar<\/span> a <\/span>vacina\u00e7\u00e3o<\/span> com as <\/span>vacinas<\/span> SCR e <\/span>tetraviral<\/span>, <\/span>dev<\/span><\/span>endo<\/span>-se <\/span>agendar<\/span> a dose da <\/span>vacina<\/span> febre<\/span> amarela<\/span> com <\/span>intervalo<\/span> de <\/span><\/span>4 <\/span>semanas<\/span><\/span><\/b>.<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/td>\n5) <\/span>Vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> em<\/span> crian\u00e7as<\/span> < 2 <\/span>anos<\/span><\/span><\/b>– – <\/span>Em<\/span> situa\u00e7\u00f5es<\/span> onde<\/span> exista<\/span> o <\/span>risco<\/span> epidemiol\u00f3gico<\/span> concomitante<\/span> para <\/span>febre<\/span> amarela<\/span> e <\/span>os<\/span> v\u00edrus<\/span> contidos<\/span> na<\/span> vacina<\/span> SCR, o <\/span>risco<\/span> da <\/span>n\u00e3o<\/span> va<\/span><\/span>cina\u00e7\u00e3o<\/span> \u00e9 <\/span>maior<\/span> que a <\/span>possibilidade<\/span> da <\/span>diminui\u00e7\u00e3o<\/span> da <\/span>resposta<\/span> imune<\/span>. Dessa forma a <\/span>vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> dever\u00e1<\/span> ser <\/span>realizada<\/span> sem<\/span> levar<\/span> em<\/span> conta<\/span> o <\/span>intervalo<\/span> entre as doses.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
          Tetraviral<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n1) <\/span>Vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> em<\/span> crian\u00e7as<\/span> < 2 <\/span>anos<\/span>\u00a0\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n
            \n
          • Para a <\/span>crian\u00e7a<\/span> que <\/span>recebeu<\/span> anteriormente<\/span> as <\/span>vacinas<\/span> tetraviral<\/span> e <\/span>febre<\/span> amarela<\/span>, as <\/span>duas<\/span> poder\u00e3o<\/span> ser <\/span>administradas<\/span> simultaneamente<\/span> ou<\/span> com <\/span>intervalo<\/span> de <\/span><\/span>4 <\/span>semanas<\/span>.\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/li>\n<\/ul>\n

            \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

            \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

            \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

            \u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n

              \n
            • Nesse <\/span>momento<\/span>, <\/span>frente<\/span> a<\/span> atual<\/span> situa\u00e7\u00e3o<\/span> epidemiol\u00f3gica<\/span> de <\/span>surto<\/span> ativo<\/span> de <\/span>sarampo<\/span> em<\/span> v\u00e1r<\/span><\/span>ios<\/span> munic\u00edpios<\/span> do <\/span>estado<\/span> de S\u00e3o Paulo, <\/span>refor\u00e7a<\/span>–<\/span>se a<\/span> necessidade<\/span> de <\/span>priorizar<\/span> a <\/span>vacina\u00e7\u00e3o<\/span> com as <\/span>vacinas<\/span> SCR e <\/span>tetraviral<\/span>, <\/span>devendo<\/span>-se <\/span>agendar<\/span> a dose da <\/span>vacina<\/span> febre<\/span> amarela<\/span> com <\/span>intervalo<\/span> de 4 <\/span>semanas<\/span>.<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/li>\n<\/ul>\n<\/td>\n
          		1) <\/span>Vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> em<\/span> crian\u00e7as<\/span> < 2 <\/span>anos<\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/p>\n
            \n
          • Para a <\/span>cr<\/span><\/span>ian\u00e7a<\/span> que <\/span>recebeu<\/span> anteriormente<\/span> as <\/span>vacinas<\/span> tretraviral<\/span> e <\/span>febre<\/span> amarela<\/span>, as <\/span>duas<\/span> poder\u00e3o<\/span> ser <\/span>administradas<\/span> simultaneamente<\/span> ou<\/span> sem<\/span> intervalo<\/span> m\u00ednimo<\/span> entre as doses. Se a <\/span>crian\u00e7a<\/span> recebeu<\/span> apenas<\/span> uma<\/span> das <\/span>vacinas<\/span> (<\/span>tretraviral<\/span> ou<\/span> febre<\/span> amarela<\/span>), <\/span>estabelecer<\/span> prefer<\/span><\/span>ivelmente<\/span> o <\/span>intervalo<\/span> de 30 <\/span>dias<\/span> entre as doses (<\/span><\/span>m\u00ednimo<\/span> 15 <\/span>dias<\/span><\/span><\/b>).\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/li>\n
          • Em<\/span> situa\u00e7\u00f5es<\/span> onde<\/span> exista<\/span> o <\/span>risco<\/span> epidemiol\u00f3gico<\/span> concomitante<\/span> para <\/span>febre<\/span> amarela<\/span> e <\/span>os<\/span> v\u00edrus<\/span> contidos<\/span> na<\/span> vacina<\/span> tetraviral<\/span> <\/span>o <\/span>risco<\/span> da <\/span>n\u00e3o<\/span> vacina\u00e7\u00e3o<\/span> \u00e9 <\/span>maior<\/span> que a <\/span>possibilidade<\/span> da <\/span>diminui\u00e7\u00e3o<\/span> da <\/span>resposta<\/span> imune<\/span>. Dessa forma a <\/span>vacina\u00e7\u00e3o<\/span> simult\u00e2nea<\/span> dever\u00e1<\/span> ser <\/span>realizada<\/span> sem<\/span> levar<\/span> em<\/span> conta<\/span> o <\/span>intervalo<\/span> entre as doses.<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
          Varicela<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nA <\/span>vacina\u00e7\u00e3o<\/span> na<\/span> p\u00f3s-exposi\u00e7\u00e3o<\/span> est\u00e1<\/span> indicada<\/span> <\/span>para <\/span>controle<\/span> de <\/span>surto<\/span> em<\/span> \u00e1reas<\/span> ind\u00edgenas<\/span>, <\/span>ambiente<\/span> hospitalar<\/span>, creches e <\/span>escolas<\/span> que <\/span>atendam<\/span> crian\u00e7as<\/span> < 7 <\/span>anos<\/span>, <\/span>funcion\u00e1rios<\/span> destas<\/span> institui\u00e7\u00f5es<\/span>. <\/span>Administrar<\/span> a <\/span>vacina<\/span> nos<\/span> comunicantes<\/span> suscet\u00edveis<\/span> imunocompetentes<\/span> at\u00e9<\/span> 120 horas (<\/span>cinco<\/span> dias<\/span>) <\/span>ap\u00f3s<\/span> o <\/span>contato<\/span>.<\/span><\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nEm<\/span> situa\u00e7\u00f5es<\/span> de <\/span>surto<\/span> de <\/span>varicela<\/span> em<\/span> creche, <\/span>em<\/span> ambiente<\/span> hospitalar<\/span> e <\/span>em<\/span> \u00e1reas<\/span> ind\u00edgenas<\/span>.\u00a0\u00a0\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n
          Pneumoc\u00f3cica<\/span> 23 <\/span>valente<\/span>\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nA <\/span>partir<\/span> de 2 <\/span>anos<\/span> de <\/span>idade<\/span>, <\/span>conforme<\/span> orienta\u00e7\u00e3o<\/span> do Manual dos Centros de <\/span>Refer\u00eancia<\/span> de <\/span>Imunobiol\u00f3gicos<\/span> Especiais<\/span> (CRIE), 5\u00aa <\/span>edi\u00e7\u00e3o<\/span> de 2019.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\nN\u00e3o<\/span> administrar<\/span> na<\/span> rotina<\/span> em<\/span> crian\u00e7as<\/span> menores<\/span> de 5 <\/span>anos<\/span>.\u00a0<\/span><\/span>\u00a0<\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

          \n","protected":false},"excerpt":{"rendered":"

          A Secretaria de Estado de Sa\u00fade divulgou uma atualiza\u00e7\u00e3o do Calend\u00e1rio Nacional de Vacina\u00e7\u00e3o 2020. O texto traz altera\u00e7\u00f5es em rela\u00e7\u00e3o \u00e0s recomenda\u00e7\u00f5es para as imuniza\u00e7\u00f5es. As mudan\u00e7as j\u00e1 haviam sido anunciadas em dezembro do ano passado pelo Minist\u00e9rio da Sa\u00fade. Entenda as modifica\u00e7\u00f5es: Vacina\u00a0\u00a0 Recomenda\u00e7\u00f5es em\u00a0\u00a0 2019\u00a0\u00a0 Passa a vigorar em 2020\u00a0\u00a0 Justificativa\u00a0\u00a0 Meningoc\u00f3cica\u00a0\u00a0<\/p>\n

          Read More<\/a><\/div>\n","protected":false},"author":2,"featured_media":54739,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19,70,13],"tags":[],"class_list":{"0":"post-54733","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-comunicacao","8":"category-destaques","9":"category-saude"},"_links":{"self":[{"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/posts\/54733"}],"collection":[{"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/comments?post=54733"}],"version-history":[{"count":1,"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/posts\/54733\/revisions"}],"predecessor-version":[{"id":54740,"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/posts\/54733\/revisions\/54740"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/media\/54739"}],"wp:attachment":[{"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/media?parent=54733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/categories?post=54733"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.lorena.sp.gov.br\/wordpress\/index.php\/wp-json\/wp\/v2\/tags?post=54733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}